Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Azithromycin in the treatment of COVID-19: a review
Daniel Echeverría-Esnal, Clara Martín‐Ontiyuelo, María Eugenia Navarrete-Rouco, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 2, pp. 147-163
Open Access | Times Cited: 233

Showing 26-50 of 233 citing articles:

Electro-polymerization of modified carbon paste sensor for detecting azithromycin
Salma Mamdouh, M. Shehata, Amany M. Fekry, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Azithromycin removal from water via adsorption on drinking water sludge-derived materials: Kinetics and isotherms studies
Camilo C. Castro-Jiménez, Julio C. Saldarriaga-Molina, Edwin Fabián García Aristizábal, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316487-e0316487
Open Access
Predictors of developing severe COVID-19 among hospitalized patients: a retrospective study
Hussain Alkhalifa, Ehab Darwish, Zaenb Alsalman, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Spironolactone as an adjuvant treatment for COVID-19: a systematic review and meta-analysis
Arman Shafiee, Mohammad Javad Amini, M. Rafiei, et al.
Future Virology (2025), pp. 1-8
Closed Access
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, et al.
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 435-449
Open Access | Times Cited: 32
Polymeric nanoparticles and nanomicelles of hydroxychloroquine co-loaded with azithromycin potentiate anti-SARS-CoV-2 effect
Aline Oliveira da Siliva de Barros, Suyene Rocha Pinto, Sara Rhaissa Rezende dos Reis, et al.
Journal of nanostructure in chemistry (2022) Vol. 13, Iss. 2, pp. 263-281
Open Access | Times Cited: 25
Environmentally azithromycin pharmaceutical wastewater management and synergetic biocompatible approaches of loaded azithromycin@hematite nanoparticles
Mostafa F. Al-Hakkani, Gamal A. Gouda, Sedky H.A. Hassan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 25
COVID-19 inflammation and implications in drug delivery
Makhloufi Zoulikha, Feifei Huang, Zhenfeng Wu, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 260-274
Open Access | Times Cited: 23
Drug safety of frequently used drugs and substances for self-medication in COVID-19
Daniela Baracaldo-Santamaría, Santiago Pabón-Londoño, Luis Carlos Rojas-Rodríguez
Therapeutic Advances in Drug Safety (2022) Vol. 13
Open Access | Times Cited: 23
Drugs for COVID-19: An Update
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8562-8562
Open Access | Times Cited: 23
Antimicrobial Activity of Azithromycin Encapsulated into PLGA NPs: A Potential Strategy to Overcome Efflux Resistance
Yasmin Abo‐zeid, Amr Amer, Marwa Reda Bakkar, et al.
Antibiotics (2022) Vol. 11, Iss. 11, pp. 1623-1623
Open Access | Times Cited: 22
Pharmacological significance of extra-oral taste receptors
Ottavio D'Urso, Filippo Drago
European Journal of Pharmacology (2021) Vol. 910, pp. 174480-174480
Closed Access | Times Cited: 31
Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19
Weifeng He, Yuan Gao, Jing Zhou, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4690-4703
Open Access | Times Cited: 21
Drugs being tested against covid-19 to slow down its spread and find effective treatment: A systematic review.
Arsalan Rasheed, Μalaika Νοοr, Τahir Usman, et al.
INTERNATIONAL JOURNAL OF ENDORSING HEALTH SCIENCE RESEARCH (IJEHSR) (2022) Vol. 10, Iss. 2, pp. 255-272
Open Access | Times Cited: 20
Antiviral effects of azithromycin: A narrative review
Saeed Khoshnood, Maryam Shirani, Amine Dalir, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112682-112682
Open Access | Times Cited: 19
Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection
Valentina Ruggiero, Rita Patrizia Aquino, Pasquale Del Gaudio, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1135-1135
Open Access | Times Cited: 19
Pharmacological approaches to pulmonary fibrosis following COVID-19
Štefan Laššán, Tomáš Tesař, J Tisonová, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
Romina Roshanshad, Amirhossein Roshanshad, Reza Fereidooni, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 4, pp. 441-459
Open Access | Times Cited: 10
Water resource rejuvenation via AOP based degradation of pharmaceuticals extensively used during COVID-19
Vineeta Singh, Shashi Prakash Gupta, Sujoy Kumar Samanta
Journal of Water Process Engineering (2024) Vol. 67, pp. 106137-106137
Closed Access | Times Cited: 3
Formulating Hypotheses for Different Study Designs
Durga Prasanna Misra, Armen Yuri Gasparyan, Olena Zimba, et al.
Journal of Korean Medical Science (2021) Vol. 36, Iss. 50
Open Access | Times Cited: 25
Regulation of autophagy by SARS‐CoV‐2: The multifunctional contributions of ORF3a
Mohd Shariq, Asrar Ahmad Malik, Javaid Ahmad Sheikh, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 9
Dental Healthcare Amid the COVID-19 Pandemic
Rabia Tariq Butt, Omer Sefvan Janjua, Sana Mehmood Qureshi, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 21, pp. 11008-11008
Open Access | Times Cited: 21
Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle
Xiaohuan Wang, Yongkang Chen, Huichun Shi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 14
Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients
Weijie Xue, Masaki Honda, Taizo Hibi
World Journal of Gastroenterology (2023) Vol. 29, Iss. 15, pp. 2283-2293
Open Access | Times Cited: 8
Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match
Mia Cokljat, Cintia Cruz, Verena I. Carrara, et al.
BMJ Global Health (2024) Vol. 9, Iss. 4, pp. e014188-e014188
Open Access | Times Cited: 2

Scroll to top